252 related articles for article (PubMed ID: 29847542)
1. Expression Levels of Interferon Regulatory Factor 5 (IRF5) and Related Inflammatory Cytokines Associated with Severity, Prognosis, and Causative Pathogen in Patients with Community-Acquired Pneumonia.
Wang X; Guo J; Wang Y; Xiao Y; Wang L; Hua S
Med Sci Monit; 2018 May; 24():3620-3630. PubMed ID: 29847542
[TBL] [Abstract][Full Text] [Related]
2. Expression of pro-inflammatory cytokines by flow-sorted alveolar macrophages in severe pneumonia.
Maus U; Rosseau S; Knies U; Seeger W; Lohmeyer J
Eur Respir J; 1998 Mar; 11(3):534-41. PubMed ID: 9596098
[TBL] [Abstract][Full Text] [Related]
3. Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia.
Paats MS; Bergen IM; Hanselaar WE; Groeninx van Zoelen EC; Hoogsteden HC; Hendriks RW; van der Eerden MM
Eur Respir J; 2013 Jun; 41(6):1378-85. PubMed ID: 23258791
[TBL] [Abstract][Full Text] [Related]
4. Serum cytokine profile contributes to discriminating M. pneumoniae pneumonia in children.
Xu XF; Li XJ; Liu JL; Wu L; Chen ZM
Cytokine; 2016 Oct; 86():73-78. PubMed ID: 27475111
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome.
Chien JY; Hsueh PR; Cheng WC; Yu CJ; Yang PC
Respirology; 2006 Nov; 11(6):715-22. PubMed ID: 17052299
[TBL] [Abstract][Full Text] [Related]
6. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.
Antunes G; Evans SA; Lordan JL; Frew AJ
Eur Respir J; 2002 Oct; 20(4):990-5. PubMed ID: 12412694
[TBL] [Abstract][Full Text] [Related]
7. Effects of age and comorbidities on serum levels of inflammatory markers in community-acquired pneumonia.
Viasus D; Simonetti AF; Estupiñan-Bohórquez AF; Carratalà J
Eur J Clin Invest; 2021 Jun; 51(6):e13480. PubMed ID: 33350464
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of interferon regulatory factor 5 associated with the risk of community-acquired pneumonia.
Wang X; Guo J; Wang Y; Xiao Y; Wang L; Hua S
Gene; 2018 Dec; 679():73-80. PubMed ID: 30176312
[TBL] [Abstract][Full Text] [Related]
9. Association of High Mobility Group Box Protein B1 Gene Polymorphisms with Pneumonia Susceptibility and Severity.
Song W; Tan H; Wang S; Zhang Y; Ding Y
Genet Test Mol Biomarkers; 2019 Jan; 23(1):3-11. PubMed ID: 30562142
[TBL] [Abstract][Full Text] [Related]
10. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study.
Montón C; Torres A; El-Ebiary M; Filella X; Xaubet A; de la Bellacasa JP
Crit Care Med; 1999 Sep; 27(9):1745-53. PubMed ID: 10507593
[TBL] [Abstract][Full Text] [Related]
11. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia.
Lee YL; Chen W; Chen LY; Chen CH; Lin YC; Liang SJ; Shih CM
J Crit Care; 2010 Mar; 25(1):176.e7-13. PubMed ID: 19592208
[TBL] [Abstract][Full Text] [Related]
12. A promising role of interferon regulatory factor 5 as an early warning biomarker for the development of human non-small cell lung cancer.
Guo J; Wang X; Wang Y; Wang L; Hua S
Lung Cancer; 2019 Sep; 135():47-55. PubMed ID: 31447002
[TBL] [Abstract][Full Text] [Related]
13. Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia.
Kolsuz M; Erginel S; Alataş O; Alataş F; Metintaş M; Uçgun I; Harmanci E; Colak O
Respiration; 2003; 70(6):615-22. PubMed ID: 14732793
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response.
Tejera A; Santolaria F; Diez ML; Alemán-Valls MR; González-Reimers E; Martínez-Riera A; Milena-Abril A
Cytokine; 2007 Jun; 38(3):117-23. PubMed ID: 17659879
[TBL] [Abstract][Full Text] [Related]
15. Expression of B and T Lymphocyte Attenuator in Patients with Severe Community-Acquired Pneumonia and the Effect of Steroid Therapy in a Mouse Model.
Zhou G; Wang D; Liu D; Qi D; Liu Z
Clin Lab; 2016 Dec; 62(12):2367-2377. PubMed ID: 28164546
[TBL] [Abstract][Full Text] [Related]
16. Characterization of common carp (Cyprinus carpio L.) interferon regulatory factor 5 (IRF5) and its expression in response to viral and bacterial challenges.
Zhu Y; Qi C; Shan S; Zhang F; Li H; An L; Yang G
BMC Vet Res; 2016 Jun; 12(1):127. PubMed ID: 27350041
[TBL] [Abstract][Full Text] [Related]
17. Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity.
Wu HP; Chen CK; Chung K; Jiang BY; Yu TJ; Chuang DY
J Formos Med Assoc; 2009 Jan; 108(1):20-7. PubMed ID: 19181604
[TBL] [Abstract][Full Text] [Related]
18. T helper 17 cells are involved in the local and systemic inflammatory response in community-acquired pneumonia.
Paats MS; Bergen IM; Hanselaar WE; van Zoelen EC; Verbrugh HA; Hoogsteden HC; van den Blink B; Hendriks RW; van der Eerden MM
Thorax; 2013 May; 68(5):468-74. PubMed ID: 23315492
[TBL] [Abstract][Full Text] [Related]
19. Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses.
Kaiser L; Fritz RS; Straus SE; Gubareva L; Hayden FG
J Med Virol; 2001 Jul; 64(3):262-8. PubMed ID: 11424113
[TBL] [Abstract][Full Text] [Related]
20. Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection.
Villinger F; Rollin PE; Brar SS; Chikkala NF; Winter J; Sundstrom JB; Zaki SR; Swanepoel R; Ansari AA; Peters CJ
J Infect Dis; 1999 Feb; 179 Suppl 1():S188-91. PubMed ID: 9988183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
